A Randomized, Double-blind, Placebo-controlled, Sequential Parallel Group, SAD/MAD Study Following Oral Administration in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MT2004
This is a randomized, double-blind, placebo-controlled, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of a single dose of MT2004 following oral single and multiple ascending dose administration.
100 Clinical Results associated with Xi'an Jiaotong University Pharmaceutical Group Co. Ltd.
0 Patents (Medical) associated with Xi'an Jiaotong University Pharmaceutical Group Co. Ltd.
100 Deals associated with Xi'an Jiaotong University Pharmaceutical Group Co. Ltd.
100 Translational Medicine associated with Xi'an Jiaotong University Pharmaceutical Group Co. Ltd.